Effect of CMNa combined with radiotherapy on the tumor immune microenvironment of mouse cervical cancer cell transplantation tumor model

References

• Cancer; IAfRo. Cancer fact sheets: cervical cancer; [ Cited 2020 Mar 03]; Available from: http://gco.iarc.fr/today/data/pdf/factsheets/cancers/cancer-fact-sheets-16.pdf
   Google Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. NCCN guidelines panel disclosures emily wyse patient advocate NCCN guidelines version 2. 2018 Cervical Cancer. [ Cited 2020 Mar 03]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf
   Google Scholar
• Orbegoso C. Murali K and Banerjee S. The current status of immunotherapy for cervical cancer [J]. Rep Pract Oncol Radiother. 2018;23(6):580–588.
   PubMedGoogle Scholar
• Franzen A, Vogt TJ, Müller T, et al. PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas. oncotarget. 2018;9(1):641–650.
   PubMedGoogle Scholar
• Balermpas P, Martin D, Wieland U, et al. Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy. Oncoimmunology. 2017, 6(3): e1288331
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein,scurfin, results in the fatal lympoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68.
   PubMed Web of Science ®Google Scholar
• Schneider T, Kimpfler S, Warth A, et al. Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma. Journal of thoracic oncology. 2011, 6(3): 432–438
   PubMed Web of Science ®Google Scholar
• Xuan C, Liu J. Research progress of immune checkpoint molecule T cell activation inhibitor immunoglobulin variable domain domain (VISTA). J Cell Mol Immunol. 2017;33(2):266–269.
   Google Scholar
• Ledi K, Yuedong H. Potential value of V-domain Ig suppressor of T-cell activation for assessing progn osis in cervical cancer and as a target for therapy. Int J Clin Exp Pathol. 2020;13(1):26–37.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li X, Fang M. Comparison of the short-term efficacy of radiotherapy combined with sodium glycididazole and radiotherapy alone in the treatment of locally advanced cervical cancer. Strait Pharm, 2018, v.30.;220(5):132–133.
   Google Scholar
• Liu Y, Wang X, Wang X. Efficacy of concurrent radiotherapy and chemotherapy combined with glycididazole sodium in the treatment of NSCLC and its influence on the expression of microRNA-21 and SIRT1. Hebei Med. 2018 (6):841–844
   Google Scholar
• Frenel JS, Le Tourneau C, O’Neil B, et al. Safety and efficacy of Pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase Ib KEYNOTE- 028 trial. Clin Oncol. 2017;35:4035–4041.
   Google Scholar
• Li Z, Song W, Rubinstein M, et al. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China cancer immunotherapy workshop in Beijing. J Hematol Oncol. 2018;11(1):142.
   PubMedGoogle Scholar
• Lines JL, Pantazi E, Mak J, et al. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 2014;74(7):1924–1932.
   PubMed Web of Science ®Google Scholar
• Le Mercier I, Chen W, Lines JL, et al. VISTA regulates the development of protective antitumor immunity. Cancer Res. 2014;74(7):1933–1944.
   PubMed Web of Science ®Google Scholar
• Wang L, Rubinstein R, Lines JL, et al. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med. 2011;208(3):577–592.
   PubMed Web of Science ®Google Scholar
• Nishikawa H. Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells. J Exp Med. 2005;201(5):681–686.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Nakata M, Hirami Y, et al. Tumor-infiltrating Foxp3+regulatory t cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2010;5(5):585–590.
   Google Scholar
• Mole RH. Whole body irradiation; radiobiology or medicine [J]? Br J Radiol. 1953;26(305):234–241.
   PubMed Web of Science ®Google Scholar
• Golden EB, Demaria S, Schiff PB, et al. An abscopal response to ra- diation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res. 2013;1(6):365–372.
   PubMed Web of Science ®Google Scholar
• Van De Walle M, Demol J, Staelens L, et al. Abscopal effect in meta- static renal cell carcinoma. Acta Clin Belg. 2016;1–5.
   Web of Science ®Google Scholar
• Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(10):925–931.
   PubMed Web of Science ®Google Scholar
• Pilones KA, Vanpouille-Box C, Demaria S. Combination of radiotherapy and immune checkpoint inhibitors. Semin Radiat Oncol. 2015;25(1):28–33.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105(4):256–265.
   PubMed Web of Science ®Google Scholar
• Penninger JM, Kroemer G. Mitochondria, AIF and caspases–rivaling for cell death execution. Nat Cell Biol. 2003;5(2):97–99.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87(1):99–163.
   PubMed Web of Science ®Google Scholar
• West AP, Khoury-Hanold W, Staron M, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nat. 2015;520(7548):553–557.
   Google Scholar
• Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Sci. 2001;292(5517):727–730.
   PubMed Web of Science ®Google Scholar
• Pedro JM, Wei Y, Sica V, et al. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 2015;11(3):452–459.
   PubMed Web of Science ®Google Scholar
• Lu T, Ramakrishnan R, Altiok S, et al. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest. 2011;121(10):4015–4029.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127(4):759–767.
   PubMed Web of Science ®Google Scholar
• Schaue D, M W X, J A R, et al. Regulatory T cells in radiotherapeutic responses. Front Oncol. 2012;2:90.
   PubMedGoogle Scholar
• Teng F, Kong L, Meng X, et al. Radiotherapy combined with immune checkpoint blockade immunotherapy: achievements and challenges. Cancer Lett. 2015;365(1):23–29.
   PubMed Web of Science ®Google Scholar
• Demaria S, Kawashima N, Yang AM, et al. Immune-mediated inhibi- tion of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res. 2005;11(2 Pt 1):728–734.
   PubMed Web of Science ®Google Scholar
• Dewan MZ, Galloway AE, Kawashima N, et al. Fractionated but not single- dose radiotherapy induces an immune- mediated abscopal effect when combined with anti- CTLA- 4 antibody. Clin Cancer Res. 2009;15(17):5379–5388.
   PubMed Web of Science ®Google Scholar
• Wu L, Wu MO, De La Maza L, et al. Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelio- ma model. Oncotarget. 2015;6(14):12468–12480.
   PubMedGoogle Scholar
• Rodriguez-Ruiz ME, Vanpouille-Box C, Melero I, et al. Immunological mechanisms responsible for radiation-induced abscopal effffect. Trends Immunol. 2018;39(8):644–655.
   PubMed Web of Science ®Google Scholar
• Twyman-Saint Victor C, A J R, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nat. 2015;520(7547):373–377.
   Google Scholar
• Herter-Sprie GS, Koyama S, Korideck H, et al. Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer. JCI Insight. 2016;1(9):e87415.
   PubMed Web of Science ®Google Scholar
• Jiang M, Jia Y, Lei K, et al. Effect of CMNa combined with Spirulina on serum TPS, sMICA, HIF-1α and Her-2 levels in patients with primary advanced cervical cancer. Adv Mod Biomed. 2017;21:4152–4155, 4178.
   Google Scholar
• Bao Y, Lu F, Ma Y. The effect of hypoxia on the expression of hypoxia-inducible factor-1α, P53 and vascular endothelial growth factor in mice. Chin J Rehabil Med. 2006;21(5):408–411.
   Google Scholar
• Dai Y, Dai Q, Zou W, et al. Effects of HIF-1α on the growth and expression of CEACAM1 and VEGF-C in nude mice with oral cancer. J Pract Stomatol. 2017;33(4):459–463.
   Google Scholar
• Obermajer N, Muthuswamy R, Lesnock J, et al. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood. 2011;118(20):5498–5505.
   PubMed Web of Science ®Google Scholar
• Juhas U, Ryba-Stanislawowska M, Szargiej P, et al. Different pathways of macrophage activation and polarization. Postepy Hig Med Dosw. 2015;69:496–502.
   Web of Science ®Google Scholar
• Doedens AL, Stockmann C, Rubinstein MP, et al. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010;70(19):7465–7475.
   PubMed Web of Science ®Google Scholar
• Powell WC, Fingleton B, Wilson CL, et al. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol. 1999;9(24):1441–1447.
   PubMed Web of Science ®Google Scholar
• Weidong L, Xueying S. The research progress of the influence mechanism of malignant tumor hypoxic acidic microenvironment on immunotherapy. World Chin J Digest. 2017;25(21):1934–1944.
   Google Scholar